UNICLONE

USPTO USPTO 2002 CANCELLED - SECTION 8

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke UNICLONE wurde als Wortmarke am 24.05.2002 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 07.10.2003 im Markenregister eingetragen. Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".

Markendetails

Markenform Wortmarke
Aktenzeichen 78131079
Registernummer 2771609
Anmeldedatum 24. Mai 2002
Veröffentlichungsdatum 15. Juli 2003
Eintragungsdatum 07. Oktober 2003

Markeninhaber

Markenvertreter

Waren und Dienstleistungen

5 Pharmaceutical and veterinarian preparations containing therapeutic proteins, therapeutic nucleicacids, gene and/or cells for health and medical care, namely, for the treatment of allergies, arthritis, cancer, diabetes, diseases of the central nervous system, inflammatory diseases, metabolic disorders, viral diseases; pharmaceutical preparations for use in cardiology and oncology; medical and pharmaceutical products, namely human vaccines, anti-infectives, diagnostic proteins, therapeutic proteins, therapeutic nucleicacids, gene and/or cells; medical, biotechnological and gene-technological products and preparations obtainable by protein-expression-banks and nucleicacid-banks together with expression-vectors, proteomics, proteome-analysis, biochips, comprising proteins and nucleicacids, protein-biochips, arrays for use in or at human beings or animals, namely, proteins; diagnostics and detergents for medical and veterinarian use, namely diagnostic preparations and reagents for clinical or medical laboratory use
9 Scientific devices and instruments for the protein-expression in a protein-expression bank, namely, protein-biochips, comprising clones for identification and validation of proteins and encoding nucleicacids together with expression-vectors thereof
42 Services for chemical, pharmaceutical, biotechnological, diagnostical, analytical, gene-technological, medical laboratories or industrial facilities or research- and development facilities, namely consulting and analysis in the field of chemistry, pharmacy, biotechnology, diagnostic, analytical, gene-technology, bio-informatics, target validation and drug development, by means of nucleicacid- or protein-biochips, protein-expression-banks, nucleicacid-banks, polypeptide or nucleicacid-libraries and arrays, automation, application and use of protein-biochips; consulting and analysis in the field of automation, application and use of proteomics, proteome studies, proteome designs, peptide and protein analytic and identification, purification and characterization, 1 D and 2D gele electrophorese, mass spectrometry, robotics for proteomics and protein-expression-banks
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1378131079